Ottawa Hospital, Regional Cancer Centre

Ottawa, Ontario K1H 8M2

1 studies enrolling now · 7 studies all time

What they study most

Anaplastic Astrocytoma, Breast Cancer, Cervical Cancer, Clear Cell RCC, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Giant Cell Glioblastoma, Glioblastoma, Glioblastoma Multiforme, Glioblastoma With Oligodendroglial Component, Gliosarcoma

Studies at this site

• A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation — Recruiting now
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling
• A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma. — Running, not enrolling
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma — Stopped early
• Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer — Completed
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed